# Case Report: Breast metastasis from biliary tract cancer: a rare case and literature review

**Authors:** Yujun Tong, Yuzhu Ji, Zhen Zhang, Xiaohong Zhang, Zhuowei Tang

PMC · DOI: 10.3389/fonc.2026.1705918 · Frontiers in Oncology · 2026-02-26

## TL;DR

A rare case of breast metastasis from biliary tract cancer is reported, emphasizing the importance of accurate diagnosis using pathology and immunohistochemistry.

## Contribution

This case report adds to the limited literature on breast metastasis from biliary tract cancer and highlights diagnostic challenges.

## Key findings

- Breast metastasis from biliary tract cancer can mimic primary breast cancer, requiring detailed pathological analysis.
- Immunohistochemistry was crucial in confirming the biliary origin of the tumor and guiding treatment decisions.

## Abstract

Breast metastasis from biliary tract cancer (BTC) is an extremely rare clinical occurrence. We report the case of a 59-year-old woman who was incidentally found to have a hepatic mass, leading to a comprehensive workup prompted by progressive chest discomfort. Clinical examination revealed a firm left breast with nipple retraction and a palpable axillary mass. Imaging confirmed a non-mass enhancement lesion in the left breast along with extensive metastases to the liver, lungs, bone, and mediastinal lymph nodes. Core needle biopsies of the breast and abdominal wall lesion showed morphologically similar adenocarcinoma. Immunohistochemistry (IHC) was instrumental in the diagnosis, demonstrating positivity for CK19 and IMP3, focal positivity for CDX2, and a high Ki-67 index (80%), while key breast markers (GATA3, ER, PR, and HER2) were all negative. This immunoprofile strongly supported a biliary origin. The patient was diagnosed with advanced BTC with multiple metastases, including to the breast. She received supportive care and was referred for systemic therapy evaluation. This case highlights that BTC breast metastasis can mimic primary breast carcinoma, underscoring the critical role of pathology and IHC in achieving an accurate diagnosis, which is essential for guiding appropriate, individualized treatment and avoiding unnecessary surgery.

## Linked entities

- **Proteins:** KRT19 (keratin 19), IMP3 (IMP U3 small nucleolar ribonucleoprotein 3), CDX2 (caudal type homeobox 2), GATA3 (GATA binding protein 3), EREG (epiregulin), PGR (progesterone receptor), ERBB2 (erb-b2 receptor tyrosine kinase 2), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** biliary tract cancer (MONDO:0003060), adenocarcinoma (MONDO:0004970)

## Full-text entities

- **Genes:** KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, GATA3 (GATA binding protein 3) [NCBI Gene 2625] {aka HDR, HDRS}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, IMP3 (IMP U3 small nucleolar ribonucleoprotein 3) [NCBI Gene 55272] {aka BRMS2, C15orf12, MRPS4}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** chest discomfort (MESH:D013898), breast carcinoma (MESH:D001943), hepatic mass (MESH:C536030), Breast metastasis (MESH:D061325), BTC (MESH:D001661), adenocarcinoma (MESH:D000230), metastases (MESH:D009362)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12979169/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12979169/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12979169/full.md

---
Source: https://tomesphere.com/paper/PMC12979169